查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1301109

吸入麻醉市場規模、份額和趨勢分析報告：按藥物、按應用、按最終用途、按地區、細分市場趨勢，2023-2030 年

Inhalation Anesthesia Market Size, Share & Trends Analysis Report By Drug (Sevoflurane, Isoflurane, Desflurane), By Application, By End-use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

吸入麻醉市場增長和趨勢

根據 GrandView Research, Inc. 最新報告，預計到 2030 年，全球吸入麻醉市場規模將達到 29.2 億美元，複合年增長率為 9.04%。

與其他選擇相比，吸入麻醉劑的誘導和恢復時間更短，療效更好，副作用更少，從而在手術過程中提供卓越的麻醉效果。 在控制病人的麻醉時間方面也有出色的表現。 由於這些優點，吸入麻醉優於靜脈麻醉。

與靜脈麻醉相比，吸入麻醉中給藥的藥物即使在低劑量下也能更快起效。 通過使用吸入途徑給藥，可以避免用藥過量，並且不會損害患者的自主神經功能。 由於這些藥物通過肺部排出體外，因此不太可能在體內蓄積。 因此，肝毒性的風險也較低。 此外，與其他替代途徑相比，通過吸入途徑給藥的藥物的耐受性和毒性水平有限。

AnaConDa（麻醉保存裝置）等創新呼吸產品的推出有助於七氟烷和異氟烷等吸入全身麻醉劑的給藥。 吸入麻醉被認為是機械通氣超過 24 小時的患者的最佳選擇，因為它可以更輕鬆地監測患者的健康狀況。

麻醉氣體主要令人擔憂的是，其中只有 5% 被患者使用，其餘 95% 被釋放到大氣中，因此這些氣體具有溫室效應。 基於大氣時間跨度和全球大氣濃度對七氟醚、異氟醚和地氟醚的比較分析表明，地氟醚對環境構成較高的潛在威脅。

吸入麻醉市場報告亮點

  • 七氟烷在 2022 年佔據最大的市場份額，因為其藥代動力學和藥效學比其他替代吸入麻醉劑具有許多優勢。
  • 地氟烷可在各種外科手術中單獨使用或與一氧化二氮和其他吸入麻醉劑結合使用。
  • 氟烷與許多並發症有關，包括氟烷引起的肝炎，並且在大多數西方國家已停止使用。
  • 由於對七氟醚和地氟醚的高需求，北美在 2022 年佔據了市場主導地位。 大公司也正在採取各種戰略舉措，這導致了美國收入的高增長。
  • 中國是亞太地區最大的經濟體。 作為世界上人口最多的國家，接受手術的患者數量也很高。 隨著大量患者的存在，許多手術正在進行中，預計將在預測期內提振市場。

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 段定義
  • 區域範圍
  • 估計/預測時間表
  • 目的
  • 調查方法
  • 信息獲取
    • 購買的數據庫
    • Gvr 內部數據庫
    • 次要信息
    • 初步調查
  • 信息或數據分析
    • 數據分析模型
  • 市場形成和驗證
  • 型號詳細信息
    • 產品流分析
  • 輔助信息列表
  • 縮寫列表

第 2 章執行摘要

  • 市場概況
  • 片段快照
  • 競爭格局快照

第三章市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場體系展望
    • 母公司市場前景
    • 相關/輔助市場前景
  • 市場動態
    • 與靜脈麻醉相比，患者預後更高
    • 越來越需要減少醫院醫療費用
    • 手術數量增加
  • 市場製約因素分析
    • 人們對溫室氣體排放的擔憂與日俱增
  • 波特五力分析
  • 杵分析
  • 管道分析

第四章藥品類型業務分析

  • 全球吸入麻醉市場：藥物變化分析
  • 七氟烷
  • 地氟烷
  • 異氟烷
  • 其他

第五章應用程序業務分析

  • 全球吸入麻醉市場：應用變化分析
  • 簡介
  • 維護

第 6 章：最終用途業務分析

  • 全球吸入麻醉市場：最終用途變化分析
  • 醫院
  • 門診手術中心
  • 其他

第七章區域業務分析

  • 2022 年和 2030 年按地區劃分的吸入麻醉市場份額
  • 北美
    • 北美吸入麻醉市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲吸入麻醉市場，2018-2030
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030 年亞太地區吸入麻醉市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲吸入麻醉市場
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • MEA 吸入麻醉市場，2018-2030 年
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 科威特

第 8 章競爭格局

  • 公司分類
  • 戰略規劃
    • 推出新產品
    • 合作夥伴關係
    • 獲取
    • 合作
    • 籌款
  • 2022 年主要參與者的市場份額分析
  • 公司熱力圖分析
  • 公司簡介
    • HALOCARBON PRODUCTS CORPORATION
    • BAXTER
    • ABBVIE INC
    • LUNAN PHARMACEUTICAL GROUP
    • PIRAMAL ENTERPRISES LTD
    • SANDOZ INTERNATIONAL GMBH
    • FRESENIUS KABI AG
Product Code: 978-1-68038-509-0

Inhalation Anesthesia Market Growth & Trends

The global inhalation anesthesia market size is expected to reach USD 2.92 billion by 2030, registering a CAGR of 9.04%, according to a new report by Grand View Research, Inc. Inhalation anesthetics offer shorter induction period and recovery time along with better efficacy and lesser adverse effects as compared to other alternatives, thus providing better anesthetic effect during surgical procedures. They also provide excellent control over the duration of anesthesia in the patient. Thus, inhalation anesthesia is being preferred over intravenous anesthesia due to these advantages.

Drugs administered through inhalation anesthesia have a quick onset of action even at low dose as compared to intravenous anesthesia. Using inhalation route for administration helps avoid excessive dosage and keeps the patient's autonomic functions intact. As these drugs are eliminated via lungs, they have lower chances of accumulation in the body. Hence, they result in lower risk of hepatotoxicity. In addition, drugs administered through inhalation route have limited tolerance and addiction level as compared to other alternatives routes.

With the launch of innovative respiratory products such as AnaConDa (Anaesthetic Conserving Device), administration of inhalation general anesthetic agents such as sevoflurane, isoflurane, & other agents have become easier. Inhalation anesthesia is considered to be the best alternative for patients who are on ventilation for more than 24 hours as it becomes easy to monitor the patient's health.

Major concern associated with anesthetic gas is that only 5% account for patient use and the rest 95% is released in the atmosphere, which leads to greenhouse effect of these gases. The comparative analysis of sevoflurane, isoflurane, and desflurane based on atmospheric time span and global atmospheric concentrations indicates that desflurane poses a high potential threat for environment.

Inhalation Anesthesia Market Report Highlights

  • Sevoflurane held the largest market share in 2022, due to the fact that its pharmacokinetics and pharmacodynamics leads to many advantages over other alternate inhaled anesthetic agents available.
  • Desflurane, alone or in combination with nitrous oxide or other inhalation anesthetic agents is used in various surgical procedures owing to its rapid onset of action and elimination rate; therefore, driving the segment demand.
  • There have been many complications reported with halothane, for instance, halothane-induced hepatitis; therefore, this anesthetic agent has been discontinued in the majority of the western countries.
  • North America dominated the market in 2022 due to the high demand for sevoflurane and desflurane in the region. Key companies are also undertaking various strategic initiatives that has led to their high revenue growth in the U.S.
  • China is the largest economy in Asia Pacific. It is a country with the maximum population in the world, hence having a large patient pool for surgeries. A large number of surgeries being performed along with the presence of a large patient pool is anticipated to boost the market over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Test Segment
      • 1.1.1.2 Service Provider Segment
      • 1.1.1.3 Application Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List of Secondary Sources
  • 1.11 List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Higher patient outcome as compared to intravenous anesthesia.
    • 3.3.2. Increasing need to reduce hospital care cost
    • 3.3.3. Rising number of surgical procedures
  • 3.4. Market restraint analysis
    • 3.4.1. Increasing concern about greenhouse gas emissions
  • 3.5. Porter's Five Forces Analysis
  • 3.6. PESTLE Analysis
  • 3.7. Pipeline Analysis

Chapter 4. Drug Type Business Analysis

  • 4.1. Global Inhalation Anesthesia Market: Drug Movement Analysis
  • 4.2. Sevoflurane
    • 4.2.1. Sevoflurane market estimates and forecasts, 2018 - 2030 (USD million)
  • 4.3. Desflurane
    • 4.3.1. Desflurane market estimates and forecasts, 2018 - 2030 (USD million)
  • 4.4. Isoflurane
    • 4.4.1. Isoflurane market estimates and forecasts, 2018 - 2030 (USD million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecasts, 2018 - 2030 (USD million)

Chapter 5. Application Business Analysis

  • 5.1. Global Inhalation Anesthesia Market: Application Movement Analysis
  • 5.2. Induction
    • 5.2.1. Induction market estimates and forecasts, 2018 - 2030 (USD million)
  • 5.3. Maintenance
    • 5.3.1. Maintenance estimates and forecasts, 2018 - 2030 (USD million)

Chapter 6. End-use Business Analysis

  • 6.1. Global Inhalation Anesthesia Market: End-use Movement Analysis
  • 6.2. Hospitals
    • 6.2.1. S Hospitals market estimates and forecasts, 2018 - 2030 (USD million)
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Ambulatory surgical centers market estimates and forecasts, 2018 - 2030 (USD million)
  • 6.4. Others
    • 6.4.1. Others market estimates and forecasts, 2018 - 2030 (USD million)

Chapter 7. Regional Business Analysis

  • 7.1. Inhalation Anesthesia Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. North America Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Target Disease Prevalence
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. Regulatory Framework
      • 7.2.2.5. Reimbursement Scenario
      • 7.2.2.6. U.S. Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. Canada Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.2. Germany
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Target Disease Prevalence
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. Regulatory Framework
      • 7.3.2.5. Reimbursement Scenario
      • 7.3.2.6. Germany Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. UK Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. France Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. Italy Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Spain Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Denmark Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Sweden Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Norway Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Target Disease Prevalence
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Regulatory Framework
      • 7.4.2.5. Reimbursement Scenario
      • 7.4.2.6. Japan Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. China Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. India Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. South Korea Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. Australia Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Thailand Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Target Disease Prevalence
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Regulatory Framework
      • 7.5.2.5. Reimbursement Scenario
      • 7.5.2.6. Brazil Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Mexico Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Scenario
      • 7.5.4.6. Argentina Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Target Disease Prevalence
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. Regulatory Framework
      • 7.6.2.5. Reimbursement Scenario
      • 7.6.2.6. South Africa Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. Saudi Arabia Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. UAE Inhalation Anesthesia Market, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. Kuwait Inhalation Anesthesia Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2022
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. HALOCARBON PRODUCTS CORPORATION
      • 8.5.1.1. Company Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. BAXTER
      • 8.5.2.1. Company Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. ABBVIE INC
      • 8.5.3.1. Company Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. LUNAN PHARMACEUTICAL GROUP
      • 8.5.4.1. Company Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. PIRAMAL ENTERPRISES LTD
      • 8.5.5.1. Company Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. SANDOZ INTERNATIONAL GMBH
      • 8.5.6.1. Company Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. FRESENIUS KABI AG
      • 8.5.7.1. Company Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Incidence of Diseases
  • Table 4 Global Inhalation Anesthesia Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 6 Global Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global. Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 8 North America Inhalation Anesthesia Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 10 North America Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 11 North America Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 12 U.S. Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 13 U.S. Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 U.S. Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 15 Canada Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 16 Canada Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 17 Canada Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 18 Europe Inhalation Anesthesia Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Europe Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 20 Europe Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 Europe Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 22 Germany Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 23 Germany Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 24 Germany Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 25 UK Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 26 UK Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 27 UK Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 28 France Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 29 France Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 30 France Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 31 Italy Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 32 Italy Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 33 Italy Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 34 Spain Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 35 Spain Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Spain Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 37 Denmark Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 38 Denmark Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 39 Denmark Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 40 Sweden Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 41 Sweden Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 42 Sweden Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 43 Norway Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 44 Norway Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 45 Norway Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Inhalation Anesthesia Market, By Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 50 Japan Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 51 Japan Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 52 Japan Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 53 China Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 54 China Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 55 China Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 56 India Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 57 India Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 India Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 59 South Korea Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 60 South Korea Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 61 South Korea Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 62 Australia Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 63 Australia Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Australia Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 65 Thailand Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 66 Thailand Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 67 Thailand Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 68 Latin America Inhalation Anesthesia Market, By Country, 2018 - 2030 (USD Million)
  • Table 69 Latin America Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 70 Latin America Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 Latin America Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 72 Brazil Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 73 Brazil Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 74 Brazil Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 75 Mexico Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 76 Mexico Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 77 Mexico Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 78 Argentina Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 79 Argentina Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 80 Argentina Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Inhalation Anesthesia Market, By Country, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 84 Middle East & Africa Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 88 South Africa Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 89 South Africa Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 90 South Africa Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 91 UAE Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 92 UAE Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 UAE Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Inhalation Anesthesia Market, By Drug, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Inhalation Anesthesia Market, By Application, 2018 - 2030 (USD Million)
  • Table 96 Kuwait Inhalation Anesthesia Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Inhalation Anesthesia Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration & Growth Prospect Mapping
  • Fig. 15 Inhalation anesthesia market: drug outlook and key takeaways
  • Fig. 16 Inhalation anesthesia market: drug movement analysis & market share 2022 & 2030
  • Fig. 17 Sevoflurane market, 2018 - 2030 (USD Million)
  • Fig. 18 Desflurane market, 2018 - 2030 (USD Million)
  • Fig. 19 Isoflurane market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 Inhalation anesthesia market: application outlook and key takeaways
  • Fig. 22 Inhalation anesthesia market: application movement analysis & market share 2022 & 2030
  • Fig. 23 Induction market, 2018 - 2030 (USD Million)
  • Fig. 24 Maintenance market, 2018 - 2030 (USD Million)
  • Fig. 25 Inhalation anesthesia market: end-use outlook and key takeaways
  • Fig. 26 Inhalation anesthesia market: end-use movement analysis & market share 2022 & 2030
  • Fig. 27 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 28 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional Marketplace: Key Takeaways
  • Fig. 31 Regional Outlook, 2022 & 2030
  • Fig. 32 Regional Market Dashboard
  • Fig. 33 Regional Market Place: Key Takeaways
  • Fig. 34 North America
  • Fig. 35 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 36 U.S.
  • Fig. 37 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Canada
  • Fig. 39 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Europe
  • Fig. 41 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 42 UK
  • Fig. 43 UK Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Germany
  • Fig. 45 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 46 France
  • Fig. 47 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Italy
  • Fig. 49 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Spain
  • Fig. 51 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark
  • Fig. 53 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Sweden
  • Fig. 55 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Norway
  • Fig. 57 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific
  • Fig. 59 Asia-Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Japan
  • Fig. 61 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 62 China
  • Fig. 63 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 64 India
  • Fig. 65 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Australia
  • Fig. 67 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Thailand
  • Fig. 69 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 70 South Korea
  • Fig. 71 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America
  • Fig. 73 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil
  • Fig. 75 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Mexico
  • Fig. 77 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Argentina
  • Fig. 79 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 80 MEA
  • Fig. 81 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 82 South Africa
  • Fig. 83 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Saudi Arabia
  • Fig. 85 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 86 UAE
  • Fig. 87 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Kuwait
  • Fig. 89 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Strategy Mapping